FIELD: genetic engineering, molecular biology. SUBSTANCE: invention proposes expressing vectors including heteropromoter T7, T3, CMV, HIV, LTR or PH and nucleic acid. Nucleic acid encodes protein 6a of human papilloma virus and it can be presented by L2, E1, E2, E4, E5a, E6 and E7. Vector transforms the yeast host-cell. Invention provides to develop prophylactic or therapeutic vaccine against pointed condyloma. EFFECT: enhanced effectiveness of vector. 8 cl, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PAPILLOMA VIRAL VACCINES | 1995 |
|
RU2206608C2 |
| PAPILLOMA VIRUS PURIFIED PROTEINS | 1995 |
|
RU2161651C2 |
| NUCLEIC ACID MOLECULE ENCODING HPV 31 L1, EXPRESSION VECTOR, HOST CELL, VIRUS-LIKE PARTICLE AND METHOD OF ITS OBTAINMENT, VACCINE, PHARMACEUTICAL COMPOSITION AND METHODS INVOLVING THEM | 2004 |
|
RU2356943C2 |
| POLYNUCLEOTIDE VACCINE FOR PAPILLOMA VIRUS | 1995 |
|
RU2173170C2 |
| OPTIMISED EXPRESSION OF HPV 58 L1 IN YEAST | 2004 |
|
RU2370538C2 |
| OPTIMISED EXPRESSION OF HPV 52 L1 IN YEAST | 2005 |
|
RU2373219C2 |
| OPTIMISED EXPRESSION LI HPV45 IN YEAST | 2004 |
|
RU2360001C2 |
| POLYNUCLEOTIDE ANTITUBERCULOSIS VACCINE | 1995 |
|
RU2186109C2 |
| DNA STRUCTURE (VARIANTS), DNA-VECTOR, IMMUNOGENIC COMPOSITION AGAINST INFLUENZA VIRUS, METHOD OF IMMUNE RESPONSE INDUCTION, VACCINE AND METHOD OF VACCINATION | 1994 |
|
RU2193065C2 |
| POLYPEPTIDES FOR INDUCTION OF PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS | 2004 |
|
RU2337108C2 |
